全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

腺病毒-腺相关病毒嵌合载体的研发趋势

DOI: 10.11830/ISSN.1000-5013.2008.02.0172

Keywords: 载体系统, 腺病毒, 腺相关病毒, 嵌合, 临床治疗

Full-Text   Cite this paper   Add to My Lib

Abstract:

分析腺病毒-腺相关病毒(Ad/AAV)嵌合载体母体中,3代Ad载体及AAV载体所具有的优势和存在的缺点.阐述Ad/AAV嵌合载体的制备方法、生产工艺,以及其在稳定转染造血干细胞、Duchenne型肌营养不良症(DMD)的基因治疗和人内啡肽基因的表达研究等方面的最新研究进展.同时指出,Ad/AAV嵌合载体是近年发展起来的嵌合病毒载体,它融合了Ad和AAV两种常用的病毒载体的优点,理论上接近理想临床应用的载体,但还需要通过大量的,特别是动物体内的应用研究去检验其优越性,以满足临床治疗需要.

References

[1]  CAVAZZANA-CALVO M, HACEIN-BEY S, DE SAINT BASILE G. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease [J]. Science, 2000.669-672.
[2]  HACEIN-BEY-ABINA S, LE DEIST F, CARLIER F. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy [J]. New England Journal of Medicine, 2002.1185-1193.doi:10.1056/NEJMoa012616.
[3]  KAY M A, MANNO C S, RAGNI M V. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector [J]. Nature Genetics, 2000.257-261.
[4]  AIUTI A, SLAVIN S, AKER M. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning [J]. Science, 2002.2410-2413.
[5]  FISHER K J. A novel adenovirus-adeno-associated virus hybrid vector that displays efficient rescue and delivery of the AAV genome [J]. Human Gene Therapy, 1996(7):2079-2087.
[6]  刁勇, 王广基, 许瑞安. 基因治疗研究进展 [J]. 药学进展, 2001(1):12-16.doi:10.3969/j.issn.1001-5094.2001.01.004.
[7]  LEHRMAN S. Virus treatment questioned after gene therapy death [J]. Nature, 1999.517-518.
[8]  GONCALVES M A, VELDE I, JANSSEN J M. Efficient generation and amplification of high-capacity adeno-associated virus/adenovirus hybrid vectors [J]. Virology, 2002.10734-10744.
[9]  GONCALVES MAFV, NIEROP G P, TIJSSEN M R. Transfer of the full-length dystrophin-coding sequence into muscle cells by a dual high-capacity hybrid viral vector with site-specific integration ability [J]. Virology, 2005(5):3146-3162.
[10]  SHAYAKHMETOV D M, CARISON C A, STECHER H. A high-capacity, capsid-modified hybrid adenovirus/adeno-associated virus vector for stable transduction of human hematopoietic cells [J]. Virology, 2002.1135-1143.doi:10.1128/JVI.76.3.1135-1143.2002.
[11]  徐学武, 俞卫锋, 崔贞福. 表达人内啡肽的腺病毒P腺相关杂合病毒的构建及体外表达分析 [J]. 微生物学报, 2005(6):856-859.doi:10.3321/j.issn:0001-6209.2005.06.008.
[12]  许瑞安, 刁勇, 谢海棠. 基因药物在临床上的最新应用和研发 [J]. 中国临床药理学与治疗学杂志, 2006, (10):1092-1097.doi:10.3969/j.issn.1009-2501.2006.10.003.
[13]  CHECK E. Gene therapy put on hold as third child develops cancer [J]. NATURE, 2005.561.
[14]  FRAEFEl C, BREAKEFIELD X O. Hybrid vectors:A new generation of virus-based vectors designed to control the cellular fate of delivered genes [J]. Gen Therapy, 1997(4):1281-1283.
[15]  RECCHIA A, PARKS R J, LAMARTINA S. Site-specific integration mediated by a hybrid adenovirus/adenoassociated virus vector [J]. Proceedings of the National Academy of Sciences(USA), 1999.2615-2620.
[16]  LIEBER A, STEINWAERDER D S, CARLSON C A. Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes [J]. Virology, 1999.9314-9324.
[17]  曲光, 徐韬, 王晋慧. 基因药物的构建与制备 [A]. 北京:北京大学出版社; 北京:北京大学医学出版社, 2007.1-35.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133